Clinical Trials Related to Hepatotoxicity

Related studies linked through entity extraction aliases.

Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity

Status: NOT_YET_RECRUITING
Phase: PHASE2

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

Status: RECRUITING
Phase: EARLY_PHASE1

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Status: RECRUITING
Phase: N/A

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

Status: COMPLETED
Phase: N/A

APAP Hepatotoxicity After Therapeutic Doses

Status: UNKNOWN
Phase: N/A

NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis

Status: UNKNOWN
Phase: NA

Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics

Status: COMPLETED
Phase: PHASE4

NAT2 in Re-challenge of INH in Patients With Hepatitis

Status: UNKNOWN
Phase: PHASE4

Acetaminophen-induced Hepatotoxicity in Chronic Alcohol Abusers

Status: COMPLETED
Phase: NA